SCHEMBL21499647

SCHEMBL21499647

CN1C(=O)C(NCc2ccc(Cl)cc2)=C(N)NC1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.37
▸ HDAC1 Q13547 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HDAC3 O15379 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ ADRA2A P08913 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20927243 0.65 VNN1 (0.40) HSD17B10HDAC1ALDH1A1CYP2C9CYP2C19
SCHEMBL21499649 0.64 MAPK1 (0.43) ALDH1A1CYP2C19HDAC6KMT2AMEN1
SCHEMBL16028787 0.62 ALDH1A1 (0.43) HSD17B10ALDH1A1FABP4KMT2AMEN1
SCHEMBL15922546 0.62 KMT2A (0.56) ALDH1A1FABP4KMT2AMEN1NPC1
SCHEMBL18833778 0.62 ALDH1A1 (0.43) HSD17B10ALDH1A1CYP2C9CYP2C19ADRA2A
SCHEMBL11935862 0.60 MEN1 (0.61) HDAC1ALDH1A1CYP2C9CYP2C19KMT2A
SCHEMBL14870251 0.59 APP (0.41) HSD17B10ALDH1A1CYP2C9CYP2C19KMT2A
SCHEMBL1505831 0.58 MEN1 (0.58) HDAC1ALDH1A1CYP2C9CYP2C19HDAC3
SCHEMBL9977792 0.58 CYP2C9 (0.65) ALDH1A1CYP2C9CYP2C19TDP1KMT2A
SCHEMBL14663091 0.57 KMT2A (0.63) ALDH1A1TDP1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 HSD17B10 1271/4885HDAC1 3987/4885ALDH1A1 1647/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 HSD17B10 1271/4885HDAC1 3987/4885ALDH1A1 1647/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 HSD17B10 1271/4885HDAC1 3987/4885ALDH1A1 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback